It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2010.
2010 | Mumbai, Maharashtra, India | ActiveSuparshva Pharma Private Limited, a active private limited company, was established on 08 June 2010 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999MH2010PTC203832. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Bhaumik Rohit Shah (Director), Nikesh Shailesh Parekh (Director), Ashwin Mehta Shantilal (Director). Past directors included Pritesh Rajeshkumar Shah, Nikesh Shailesh Parekh, Ankit Hemant Shah. It holds ₹9.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1St Floor, Gala No. 6, Hitex Industrial Estate, Behind Petrol Pump, S.V. Road, Dahisar E, Ast,, Mumbai, Maharashtra, 400068.
U74999MH2010PTC203832
203832
08 June 2010
₹3.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Suparshva Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhaumik Rohit Shah | Director | 08 Jun 2010 | Current |
| Nikesh Shailesh Parekh | Director | 08 Jan 2011 | Current |
| Ashwin Mehta Shantilal | Director | 08 Jun 2010 | Current |
| Ankit Hemant Shah | Director | 03 Dec 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Dec 2010 | Past |
| Pramod Abcsdd | Additional Director | 05 Dec 2011 | Past |
| Pramod Abcsdd | Additional Director | 05 Dec 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Suparshva Pharma Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 89.18% decrease. The company also saw a substantial fall in profitability, with a 86% decrease in profit. The company's net worth moved up by a moderate rise of 2.7%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Suparshva Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Oct 2011 | Vasai Vikas Sahakari Bank Ltd | ₹9.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Suparshva Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Suparshva Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suparshva Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Suparshva Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Suparshva Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
A charge with Vasai Vikas Sahakari Bank Ltd amounted to Rs. 9.00 M with Charge ID 10318552 was registered on 10 Oct 2011. was recorded as a recent event.
Nikesh Shailesh Parekh was appointed as a Director was appointed as a Director on 08 Jan 2011 & has been associated with this company since 14 years 10 months . was recorded as a recent event.
Progress on Ankit Hemant Shah was appointed as a Director was appointed as a Director on 03 Dec 2010 & has been associated with this company since 14 years 11 months . was documented.
Progress on Bhaumik Rohit Shah was appointed as a Director was appointed as a Director on 08 Jun 2010 & has been associated with this company since 15 years 5 months . was documented.
The CIN of Suparshva Pharma Private Limited is U74999MH2010PTC203832.
Suparshva Pharma Private Limited is headquartered at 1St Floor, Gala No. 6, Hitex Industrial Estate, Behind Petrol Pump, S.V. Road, Dahisar E, Ast,, Mumbai, Maharashtra, 400068.
Suparshva Pharma Private Limited was incorporated on 08 June 2010.
The current directors of Suparshva Pharma Private Limited are
The primary industry of Suparshva Pharma Private Limited is Pharma.
Suparshva Pharma Private Limited is unlisted.
The authorized capital of Suparshva Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Suparshva Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX